CICCIA, Francesco
 Distribuzione geografica
Continente #
EU - Europa 2.502
NA - Nord America 2.345
AS - Asia 686
SA - Sud America 31
AF - Africa 3
Totale 5.567
Nazione #
US - Stati Uniti d'America 2.335
IE - Irlanda 1.299
GB - Regno Unito 382
CN - Cina 305
SG - Singapore 279
IT - Italia 267
DE - Germania 175
GR - Grecia 172
FR - Francia 50
SE - Svezia 43
KR - Corea 42
FI - Finlandia 28
BR - Brasile 23
UA - Ucraina 20
IN - India 19
BE - Belgio 17
TR - Turchia 17
CZ - Repubblica Ceca 10
CA - Canada 9
HK - Hong Kong 9
NL - Olanda 7
RU - Federazione Russa 7
CH - Svizzera 6
ES - Italia 6
CO - Colombia 5
RS - Serbia 5
JP - Giappone 4
MY - Malesia 4
CL - Cile 3
EG - Egitto 3
PL - Polonia 3
MD - Moldavia 2
MK - Macedonia 2
TH - Thailandia 2
BY - Bielorussia 1
GL - Groenlandia 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 5.567
Città #
Dublin 1.299
Santa Clara 564
Jacksonville 397
Princeton 187
Roxbury 187
Chandler 176
Singapore 158
Medford 140
Bremen 121
Beijing 72
Des Moines 61
Ann Arbor 51
Cambridge 50
Naples 50
Boardman 47
New York 46
Seoul 41
Wilmington 41
Jinan 34
Nanjing 24
Dearborn 20
Hefei 20
Hebei 16
Caserta 14
Brussels 13
Helsinki 12
Lappeenranta 12
Shenyang 12
Ashburn 11
Guangzhou 11
Norwalk 11
Redwood City 10
Brno 9
Havertown 9
Rome 9
Nanchang 8
Palermo 8
Pune 8
London 7
Munich 7
Ningbo 7
Shanghai 7
Taiyuan 7
Berlin 6
Changsha 6
Kunming 6
Los Angeles 6
Tianjin 6
Bagnoli Irpino 5
Boston 5
Groningen 5
Hangzhou 5
Houston 5
Ottawa 5
Vicenza 5
Bogotá 4
Hong Kong 4
Hyderabad 4
Kostroma 4
Milan 4
Mugnano di Napoli 4
San Severo 4
Wanchai 4
Woodbridge 4
Atlanta 3
Campina Grande 3
El Segundo 3
Elora 3
Florence 3
Frankfurt am Main 3
Gaziantep 3
Gunzenhausen 3
Haikou 3
Harlow 3
Jiaxing 3
João Pessoa 3
Lanzhou 3
Marseille 3
Miano 3
Napoli 3
Sant'Angelo in Formis 3
Santiago 3
Saviano 3
Taizhou 3
Taranto 3
Valencia 3
Villa Literno 3
Zhengzhou 3
Aracaju 2
Avellino 2
Baotou 2
Catania 2
Chisinau 2
Cortona 2
Council Bluffs 2
Curitiba 2
Fuzhou 2
Gent 2
Huamu 2
Knokke-heist 2
Totale 4.191
Nome #
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 85
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 64
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 56
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 53
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 51
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 50
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 49
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 49
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 48
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 46
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 45
Gut dysbiosis in Spondyloarthritis: Cause or effect? 43
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 42
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 42
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 41
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 41
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 40
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 39
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 39
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 39
Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis? 38
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 36
Autophagy in the pathogenesis of ankylosing spondylitis 36
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 36
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 36
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 36
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis 35
Role of subclinical gut inflammation in the pathogenesis of spondyloarthritis 35
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 35
The level of soluble Granzyme A is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease 34
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 34
Cardiovascular disease in primary sjögren’s syndrome 34
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 34
Intestinal Involvement in Kawasaki Disease 33
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 33
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 33
ILC3 in Axial Spondyloarthritis: the Gut Angle 33
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 32
Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus 32
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 32
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 32
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 31
Gut inflammation in spondyloarthritis 31
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 31
Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease 30
Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease 30
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome 30
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 30
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis? 30
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 30
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 30
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 30
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 28
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 28
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome 28
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 28
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 28
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 28
DIASTOLIC DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF BLOCKING AGENTS 27
IVIG in APS pregnancy 27
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 27
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 27
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 27
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis 27
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 26
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 26
PERIPHERAL AND INTESTINAL CD4+CD25HIGH T REGULATORY CELLS ARE EXPANDED IN ANKYLOSING SPONDYLITIS PATIENTS 26
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 26
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 26
Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease 26
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 26
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 26
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 26
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 26
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 26
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 25
OVER-EXPRESSION OF HUMAN DEFENSIN 5 IN THE SUBCLINICALLY INFLAMED GUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS 25
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 25
The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis 25
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 25
Subclinical gut inflammation in ankylosing spondylitis 25
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 25
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 25
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 25
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 24
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 24
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 24
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 24
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 24
Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro 24
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis 24
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 24
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 24
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 24
Prevalence of headache in patients with Behçet's disease without overt neurological involvement 24
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 24
The craniovertebral junction in rheumatoid arthritis: State of the art 24
Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis 24
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 24
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 24
Totale 3.239
Categoria #
all - tutte 41.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020413 0 0 0 0 28 32 216 51 20 19 34 13
2020/2021593 10 8 21 37 109 6 146 12 39 16 181 8
2021/20221.010 21 11 1 24 372 4 37 16 48 28 66 382
2022/20231.724 246 12 26 17 208 59 4 60 1.020 5 43 24
2023/20241.034 35 30 39 55 368 101 27 29 11 7 57 275
2024/2025801 14 46 10 88 643 0 0 0 0 0 0 0
Totale 5.928